Federal Register: June 11, 2007 (Volume 72, Number 111)
DOCID: fr11jn07-105 FR Doc E7-11224
DEPARTMENT OF VETERANS AFFAIRS
Veterans Affairs Department
ACTION: Patent licenses; non-exclusive, exclusive, or partially exclusive:
DOCUMENT ACTION: Notice of Intent.
Notice of Intent To Grant an Exclusive License
DATES: Comments must be received within fifteen (15) days from the date of this published Notice.
Notice is hereby given that the Department of Veterans Affairs, Office of Research and Development, intends to grant to Perlegen Sciences, Inc., 2021 Stierlin Court, Mountain View, CA 94043 USA an exclusive license to practice the following patent application: U.S. Patent Application Serial No. 11/344,975 filed January 31, 2006 entitled ``Genetic Basis of Alzheimer's Disease and Diagnosis and Treatment Thereof.''
Perlegen Sciences, Inc.,
It is in the public interest to so license
these inventions as Perlegen Sciences, Inc. submitted a complete and
sufficient application for a license. The prospective exclusive license
will be royaltybearing and will comply with the terms and conditions
of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license
may be granted unless, within fifteen (15) days from the date of this
published Notice, the Department of Veterans Affairs Office of Research
and Development receives written evidence and argument which
establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Dated: June 5, 2007.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. E711224 Filed 6807; 8:45 am]
BILLING CODE 832001P
FOR FURTHER INFORMATION CONTACT
Copies of the published patent applications may be obtained from the U.S. Patent and Trademark Office at http://www.uspto.gov.